奥精医疗科技股份有限公司股东减持股份计划公告

Core Viewpoint - The announcement details a share reduction plan by major shareholder Beijing Qilun Tianyou Venture Capital Co., Ltd. for Aojing Medical Technology Co., Ltd., indicating a planned reduction of up to 1,355,515 shares, which represents 1% of the total shares outstanding [3][6]. Group 1: Major Shareholder Information - As of the announcement date, Qilun Tianyou holds 8,468,000 shares, accounting for 6.18% of Aojing Medical's total shares [2]. - The shares held by Qilun Tianyou were acquired prior to the company's initial public offering and have been tradable since May 23, 2022 [2]. Group 2: Share Reduction Plan Details - Qilun Tianyou plans to reduce its holdings through centralized bidding and block trading, with a maximum reduction of 1,355,515 shares [3]. - The reduction will occur within three months following a 15-day period after the announcement, specifically from October 23, 2025, to January 23, 2026 [3]. Group 3: Compliance and Commitments - Qilun Tianyou has previously committed to not transferring or entrusting the management of its shares for twelve months following the company's stock listing [5]. - The current reduction plan is consistent with prior commitments made by the major shareholder [6]. Group 4: Other Shareholder Activities - BioVeda China RMB Investment Limited has also reduced its holdings, decreasing its stake to 5% after selling 388,928 shares, which is 0.28% of the total shares [12][13]. - The reduction by BioVeda does not trigger a change in control of the company and complies with relevant regulations [12][16].